Cabozantinib treatment &ndash case report
dc.contributor.author | Richter Igor | cs |
dc.contributor.author | Dvořák Josef | cs |
dc.date.accessioned | 2021-01-14T18:07:30Z | |
dc.date.available | 21-00-2020 | en |
dc.date.available | 2021-01-14T18:07:30Z | |
dc.date.issued | 2020 | cs |
dc.date.updated | 21-01-2020 | en |
dc.format.extent | 3 | cs |
dc.identifier.issn | 2464-7195 | cs |
dc.identifier.uri | https://dspace.tul.cz/handle/15240/158707 | |
dc.language.iso | cze | cs |
dc.relation.ispartof | Onkologická revue | en |
dc.relation.ispartofseries | 0 | cs |
dc.subject | renal cell carcinoma | cs |
dc.subject | VEGFR inhibitors | cs |
dc.subject | sunitinib | cs |
dc.subject | pazopanib | cs |
dc.subject | cabozantinib | cs |
dc.title | Cabozantinib treatment &ndash case report | en |
dc.title | Léčba cabozantinibem &ndash kazuistika | cs |
local.citation.epage | 1-3 | cs |
local.citation.spage | 1-3 | cs |
local.identifier.publikace | 8034 | |
local.relation.issue | 4 | cs |